Statistics on the use of cardiac electronic devices and electrophysiological procedures in 55 ESC countries: 2013 report from the European Heart Rhythm Association (EHRA).

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Europace

• Publication date

  2014-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/europace/euu049PMID 24755466
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Financial crisis, austerity, and health in Europe.

  2013cited by this paper
• Austerity policies in Europe—bad for health

  2013cited by this paper
• Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association.

  2013cited by this paper
• Current practice in transvenous lead extraction: a European Heart Rhythm Association EP Network Survey.

  2012cited by this paper
• The EHRA White Book.

  2012cited by this paper
• The role of echocardiography in stroke risk assessment in patients with atrial fibrillation: is it additive or does it simply echo clinical risk factors?

  2012cited by this paper
• Pathways for training and accreditation for transvenous lead extraction: a European Heart Rhythm Association position paper.

  2012cited by this paper
• Barriers to implementation of evidence-based electrical therapies and the need for outcome research: role of European registries.

  2011cited by this paper
• Health economics and the European Heart Rhythm Association.

  2011cited by this paper
• Attitude towards redundant leads and the practice of lead extractions: a European survey.

  2010cited by this paper
• Health economics and outcomes research: a new challenge and field of action for the European Heart Rhythm Association.

  2010cited by this paper

• Mortality and use of implantable cardioverter defibrillators in patients with low ejection fraction following non-ST-segment elevation myocardial infarction

  2025cites this paper
• Cardiac Implantable Electronic Devices - What We Have Done So Far? A Single-center Experience

  2022cites this paper
• Assessing the safety of interrogating cardiac-implantable electronic devices with brand-mismatched remote interrogators: a pilot study

  2022cites this paper
• Performance-based risk-sharing arrangements for devices and procedures in cardiac electrophysiology: an innovative perspective.

  2022cites this paper
• Surgical management of delayed right heart perforation following antiarrhythmic device implantation

  2021cites this paper
• Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices.

  2020cites this paper
• Assessment of Factors Determining Efficacy of Cardiac Resynchronisation Therapy for Patients with Heart Failure in the Population of Latvia. Summary of the Doctoral Thesis

  2020cites this paper
• Sirds resinhronizācijas iekārtu implantācijas efektivitātes kritēriju izvērtējums pacientiem ar sirds mazspēju Latvijas populācijā. Promocijas darba kopsavilkums

  2020cites this paper
• Occult bacteraemia in cardiac implantable electronic device patients: a review of diagnostic workflow and mandatory therapy

  2019cites this paper
• Assessment of Cardiac Resynchronisation Therapy Efficacy Determining Factors for Patients with Moderate and Severe Heart Failure in the Population of Latvia in a 12 and 24 Month Study

  2018cites this paper
• Pacemaker Stimulation Criticism at ECG

  2018cites this paper
• Five year trends (2008–2012) in cardiac implantable electrical device utilization in five European nations: a case study in cross-country comparisons using administrative databases

  2018cites this paper
• New-onset pericardial effusion during transvenous lead extraction: incidence, causative mechanisms, and associated factors

  2018cites this paper
• Implantable cardioverter–defibrillator therapy in Australia, 2002–2015

  2018cites this paper
• 44 – Social and Ethical Principles of Device Therapy: The Ethics of Cardiac Implantable Electronic Device Reuse and Deactivation

  2017cites this paper
• A Decade of Information on the Use of Cardiac Implantable Electronic Devices and Interventional Electrophysiological Procedures in the European Society of Cardiology Countries: 2017 Report from the European Heart Rhythm Association

  2017cites this paper
• Investigating Regional Variation of Cardiac Implantable Electrical Device Implant Rates in European Healthcare Systems: What Drives Differences?

  2017cites this paper
• Improved cardiac magnetic resonance thermometry and dosimetry for monitoring lesion formation during catheter ablation

  2017cites this paper
• Temporal Trends and Temperature-Related Incidence of Electrical Storm: The TEMPEST Study (Temperature-Related Incidence of Electrical Storm)

  2017cites this paper
• Cardiac Resynchronization Therapy: An Overview on Guidelines.

  2017cites this paper
• Validation of Algorithms to Identify Invasive Electrophysiology Procedures Using Administrative Data in Ontario, Canada

  2017cites this paper
• 43 – Establishing and Managing a Device Clinic and Database

  2017cites this paper
• Cardiac resynchronization therapy in the real world: need to focus on implant rates, patient selection, co-morbidities, type of devices, and complications

  2017cites this paper
• Venous stenosis and occlusion in the presence of endocardial leads in patients referred for transvenous lead extraction

  2017cites this paper
• Adoption Decisions for Medical Devices in the Field of Cardiology: Results from a European Survey.

  2017cites this paper
• Cardiac MR thermometry for the monitoring of radiofrequency ablation

  2016cites this paper
• Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise.

  2016cites this paper
• Polish and European management strategies in patients with atrial fibrillation. Data from the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot).

  2016cites this paper
• Diagnose bradykarder Herzrhythmusstörungen

  2016cites this paper
• Access to and clinical use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology Countries: 2016 Report from the European Heart Rhythm Association.

  2016cites this paper
• Implant rates of cardiac implantable electrical devices in Europe: A systematic literature review.

  2016cites this paper
• The utility of a CHA2DS2-VASc score in predicting the presence of significant stenosis and occlusion of veins with indwelling endocardial leads.

  2016cites this paper
• Perioperative management of antithrombotic treatment during implantation or revision of cardiac implantable electronic devices: the European Snapshot Survey on Procedural Routines for Electronic Device Implantation (ESS-PREDI).

  2016influential citation
• Performance of 2014 NICE defibrillator implantation guidelines in heart failure risk stratification

  2016cites this paper
• Long-term follow-up of patients with implantable cardioverter defibrillators in Greece: The Cretan Registry.

  2016cites this paper
• Incidence of arrhythmias in a large cohort of patients with current implantable cardioverter-defibrillators in Spain: results from the UMBRELLA Registry.

  2016cites this paper
• Thirteen-year nationwide trends in use of implantable cardioverter-defibrillators and subsequent long-term survival.

  2015cites this paper
• Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association.

  2015cites this paper
• Clinical management of electromagnetic interferences in patients with pacemakers and implantable cardioverter-defibrillators: review of the literature and focus on magnetic resonance conditional devices

  2015cites this paper
• Magnetic Resonance Imaging in Patients with Implanted Cardiac Devices

  2015cites this paper
• Cardiac n Therapy: An Overview on Guidelines

  2015cites this paper
• Remote monitoring of cardiac implantable electrical devices in Europe: quo vadis?

  2015cites this paper
• Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association.

  2015cites this paper
• Asymptomatic atrial fibrillation: clinical correlates, management, and outcomes in the EORP-AF Pilot General Registry.

  2015cites this paper
• Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials.

  2015cites this paper
• Profile of St. Jude Medical’s Allure Quadra quadripolar pacemaker system for cardiac resynchronization therapy

  2015cites this paper
• Calcium leak induced sinus bradycardia

  2015cites this paper
• Clinical utility of routine use of continuous transesophageal echocardiography monitoring during transvenous lead extraction procedure.

  2015cites this paper
• Advances in Arrhythmia and Electrophysiology

  2015cites this paper
• Cardiac Resynchronization Therapy: An Overview on Guidelines.

  2015cites this paper
• HCN4 mutations in multiple families with bradycardia and left ventricular noncompaction cardiomyopathy.

  2014cites this paper
• Registro Español de Marcapasos. XI Informe Oficial de la Sección de Estimulación Cardiaca de la Sociedad Española de Cardiología (2013)

  2014cites this paper
• Cardiac resynchronization therapy: implant rates, temporal trends and relationships with heart failure epidemiology

  2014cites this paper
• Spanish Pacemaker Registry. Eleventh official report of the Spanish Society of Cardiology Working Group on Cardiac Pacing (2013).

  2014cites this paper
• Review Article On the Underutilization of Cardiac Resynchronization Therapy

  2014cites this paper